Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 98

1.

Correlation of cerebral spinal fluid pH and HCO3- with disease progression in ALS.

Morimoto N, Deguchi K, Sato K, Yunoki T, Deguchi S, Ohta Y, Kurata T, Takao Y, Ikeda Y, Matsuura T, Abe K.

J Neurol Sci. 2011 Aug 15;307(1-2):74-8. doi: 10.1016/j.jns.2011.05.013. Epub 2011 May 31.

PMID:
21632065
[PubMed - indexed for MEDLINE]
2.

Transglutaminase activity in serum and cerebrospinal fluid in sporadic amyotrophic lateral sclerosis: a possible use as an indicator of extent of the motor neuron loss.

Fujita K, Honda M, Hayashi R, Ogawa K, Ando M, Yamauchi M, Nagata Y.

J Neurol Sci. 1998 Jun 11;158(1):53-7.

PMID:
9667778
[PubMed - indexed for MEDLINE]
3.

Vascular endothelial growth factor attenuates neurodegenerative changes in the NSC-34 motor neuron cell line induced by cerebrospinal fluid of sporadic amyotrophic lateral sclerosis patients.

Kulshreshtha D, Vijayalakshmi K, Alladi PA, Sathyaprabha TN, Nalini A, Raju TR.

Neurodegener Dis. 2011;8(5):322-30. doi: 10.1159/000323718. Epub 2011 Mar 10.

PMID:
21389676
[PubMed - indexed for MEDLINE]
4.

Reduced angiotensin II levels in the cerebrospinal fluid of patients with amyotrophic lateral sclerosis.

Kawajiri M, Mogi M, Higaki N, Tateishi T, Ohyagi Y, Horiuchi M, Miki T, Kira JI.

Acta Neurol Scand. 2009 May;119(5):341-4. doi: 10.1111/j.1600-0404.2008.01099.x. Epub 2008 Sep 16.

PMID:
18798831
[PubMed - indexed for MEDLINE]
5.

Cerebrospinal fluid tau protein is not a biological marker in amyotrophic lateral sclerosis.

Paladino P, Valentino F, Piccoli T, Piccoli F, La Bella V.

Eur J Neurol. 2009 Feb;16(2):257-61. doi: 10.1111/j.1468-1331.2008.02405.x. Epub 2008 Dec 9.

PMID:
19138331
[PubMed - indexed for MEDLINE]
6.

Decreased cerebrospinal fluid cytochrome c levels in patients with amyotrophic lateral sclerosis.

Iłzecka J.

Scand J Clin Lab Invest. 2007;67(3):264-9.

PMID:
17454840
[PubMed - indexed for MEDLINE]
7.

Microglial upregulation of progranulin as a marker of motor neuron degeneration.

Philips T, De Muynck L, Thu HN, Weynants B, Vanacker P, Dhondt J, Sleegers K, Schelhaas HJ, Verbeek M, Vandenberghe R, Sciot R, Van Broeckhoven C, Lambrechts D, Van Leuven F, Van Den Bosch L, Robberecht W, Van Damme P.

J Neuropathol Exp Neurol. 2010 Dec;69(12):1191-200. doi: 10.1097/NEN.0b013e3181fc9aea.

PMID:
21107132
[PubMed - indexed for MEDLINE]
8.

Intrathecal upregulation of granulocyte colony stimulating factor and its neuroprotective actions on motor neurons in amyotrophic lateral sclerosis.

Tanaka M, Kikuchi H, Ishizu T, Minohara M, Osoegawa M, Motomura K, Tateishi T, Ohyagi Y, Kira J.

J Neuropathol Exp Neurol. 2006 Aug;65(8):816-25.

PMID:
16896315
[PubMed - indexed for MEDLINE]
9.

Axonal damage markers in cerebrospinal fluid are increased in ALS.

Brettschneider J, Petzold A, Süssmuth SD, Ludolph AC, Tumani H.

Neurology. 2006 Mar 28;66(6):852-6.

PMID:
16567701
[PubMed - indexed for MEDLINE]
10.

CSF glial markers correlate with survival in amyotrophic lateral sclerosis.

Süssmuth SD, Sperfeld AD, Hinz A, Brettschneider J, Endruhn S, Ludolph AC, Tumani H.

Neurology. 2010 Mar 23;74(12):982-7. doi: 10.1212/WNL.0b013e3181d5dc3b.

PMID:
20308682
[PubMed - indexed for MEDLINE]
11.

Cerebrospinal fluid vascular endothelial growth factor in patients with amyotrophic lateral sclerosis.

Iłzecka J.

Clin Neurol Neurosurg. 2004 Sep;106(4):289-93.

PMID:
15297002
[PubMed - indexed for MEDLINE]
12.

Erythropoietin concentration in serum and cerebrospinal fluid of patients with amyotrophic lateral sclerosis.

Janik P, Kwiecinski H, Sokolowska B, Niebroj-Dobosz I.

J Neural Transm. 2010 Mar;117(3):343-7. doi: 10.1007/s00702-009-0354-2. Epub 2009 Dec 12.

PMID:
20012656
[PubMed - indexed for MEDLINE]
13.

Increased cerebrospinal fluid levels of substance P in patients with amyotrophic lateral sclerosis. Short communication.

Matsuishi T, Nagamitsu S, Shoji H, Itoh M, Takashima S, Iwaki T, Shida N, Yamashita Y, Sakai T, Kato H.

J Neural Transm. 1999;106(9-10):943-8.

PMID:
10599876
[PubMed - indexed for MEDLINE]
14.

Glutamate levels in cerebrospinal fluid in amyotrophic lateral sclerosis: a reappraisal using a new HPLC method with coulometric detection in a large cohort of patients.

Spreux-Varoquaux O, Bensimon G, Lacomblez L, Salachas F, Pradat PF, Le Forestier N, Marouan A, Dib M, Meininger V.

J Neurol Sci. 2002 Jan 15;193(2):73-8.

PMID:
11790386
[PubMed - indexed for MEDLINE]
15.

Elevated cerebrospinal fluid neurofilament light levels in patients with amyotrophic lateral sclerosis: a possible marker of disease severity and progression.

Tortelli R, Ruggieri M, Cortese R, D'Errico E, Capozzo R, Leo A, Mastrapasqua M, Zoccolella S, Leante R, Livrea P, Logroscino G, Simone IL.

Eur J Neurol. 2012 Dec;19(12):1561-7. doi: 10.1111/j.1468-1331.2012.03777.x. Epub 2012 Jun 11.

PMID:
22680408
[PubMed - indexed for MEDLINE]
16.

Neurofilament heavy subunit in cerebrospinal fluid: a biomarker of amyotrophic lateral sclerosis?

Mendonça DM, Martins SC, Higashi R, Muscara MN, Neto VM, Chimelli L, Martinez AM.

Amyotroph Lateral Scler. 2011 Mar;12(2):144-7. doi: 10.3109/17482968.2010.542002. Epub 2011 Jan 4.

PMID:
21198418
[PubMed - indexed for MEDLINE]
17.

Phosphorylated neurofilament heavy subunit (pNF-H) in peripheral blood and CSF as a potential prognostic biomarker in amyotrophic lateral sclerosis.

Boylan KB, Glass JD, Crook JE, Yang C, Thomas CS, Desaro P, Johnston A, Overstreet K, Kelly C, Polak M, Shaw G.

J Neurol Neurosurg Psychiatry. 2013 Apr;84(4):467-72. doi: 10.1136/jnnp-2012-303768. Epub 2012 Oct 31.

PMID:
23117489
[PubMed - indexed for MEDLINE]
18.

Altered in-vitro and in-vivo expression of glial glutamate transporter-1 following exposure to cerebrospinal fluid of amyotrophic lateral sclerosis patients.

Shobha K, Vijayalakshmi K, Alladi PA, Nalini A, Sathyaprabha TN, Raju TR.

J Neurol Sci. 2007 Mar 15;254(1-2):9-16. Epub 2007 Jan 24.

PMID:
17254611
[PubMed - indexed for MEDLINE]
19.

Cerebrospinal fluid erythropoietin (EPO) in amyotrophic lateral sclerosis.

Brettschneider J, Widl K, Schattauer D, Ludolph AC, Tumani H.

Neurosci Lett. 2007 Apr 18;416(3):257-60. Epub 2007 Feb 3.

PMID:
17368721
[PubMed - indexed for MEDLINE]
20.

Soluble beta-amyloid precursor protein is related to disease progression in amyotrophic lateral sclerosis.

Steinacker P, Fang L, Kuhle J, Petzold A, Tumani H, Ludolph AC, Otto M, Brettschneider J.

PLoS One. 2011;6(8):e23600. doi: 10.1371/journal.pone.0023600. Epub 2011 Aug 15.

PMID:
21858182
[PubMed - indexed for MEDLINE]
Free PMC Article

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk